TELCON RF PHARMACEUTICAL. Inc.

Research TELCON RF PHARMACEUTICAL. Inc. (200230.KQ) on Bullrun: market cap KRW 15.53B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker200230.KQ
ExchangeKQ
CountrySouth Korea
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CurrencyKRW
Market capKRW 15.53B
Financial periodQ2 2026
RevenueKRW 28.94B
Net income-KRW 10.98B
Free cash flowKRW 161.01M
Gross margin44.9%

Valuation Snapshot

latest market cap is KRW 15.53B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	KRW 15.53B	n/a	n/a	n/a

Dividend history

About TELCON RF PHARMACEUTICAL. Inc.

TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea.

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

Dongwha Pharm.Co.,Ltd (000020.KS) Yuhan Corporation (000100.KS) Yuyu Pharma, Inc. (000220.KS) Ildong Holdings Co., Ltd. (000230.KS) Samil Pharmaceutical Co.,Ltd (000520.KS) Dong-A Socio Holdings Co., Ltd. (000640.KS) JW Pharmaceutical Corporation (001060.KS) SAMSUNG PHARM. Co., LTD. (001360.KS) Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) Chong Kun Dang Holdings Corp. (001630.KS) Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) HANDOK Inc. (002390.KS)

Frequently asked questions

What is TELCON RF PHARMACEUTICAL. Inc.'s market cap?

TELCON RF PHARMACEUTICAL. Inc.'s market capitalization is KRW 15.53B.